Location History:
- Spring House, PA (US) (2024)
- Blue Bell, PA (US) (2024)
Company Filing History:
Years Active: 2024-2025
Title: **Innovator Spotlight: Raymond Brittingham**
Introduction
Raymond Brittingham, an accomplished inventor based in Blue Bell, PA, has significantly contributed to the field of biotechnology. With a singular patent to his name, Brittingham has demonstrated his expertise in developing innovative binding domains that target essential proteins in the immune system.
Latest Patents
Raymond Brittingham holds a patent for "Proteins comprising CD3 antigen binding domains and uses thereof." This innovative disclosure details antigen binding domains that specifically bind the cluster of differentiation 3 (CD3) protein, including those that target CD3ε. The patent encompasses polynucleotides encoding these domains, vectors, host cells, as well as methods of producing and utilizing them, highlighting Brittingham's impactful work in advancing therapeutic mechanisms.
Career Highlights
Raymond Brittingham is currently affiliated with Janssen Biotech, Inc., a leading company in the biotech sector. His work at this prestigious organization underscores his commitment to advancing medical science through innovative solutions. With a focus on antibody development and immune therapies, Brittingham plays a pivotal role in transformative research that can lead to breakthroughs in treating various diseases.
Collaborations
Throughout his career, Brittingham has collaborated with notable colleagues such as Adam Zwolak and Scott R Brodeur. Their partnerships exemplify the collaborative spirit that is crucial for innovation in the fast-paced realm of biotechnology, where diverse expertise often leads to significant advancements.
Conclusion
As an inventor, Raymond Brittingham's contributions to the field of biotechnology are both impactful and inspiring. His singular patent reflects a deep understanding of the immune system and a commitment to developing new therapeutic solutions. Through collaborative efforts at Janssen Biotech, Brittingham's work exemplifies the potential of innovative research in improving healthcare outcomes.